Ranolazine pretreatment in patients with coronary artery disease undergoing elective percutaneous coronary intervention

Trial Profile

Ranolazine pretreatment in patients with coronary artery disease undergoing elective percutaneous coronary intervention

Not stated
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2011

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Myocardial infarction; Myocardial reperfusion injury
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Dec 2011 Results of this trial are expected by 2012.
    • 07 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top